Inclusion Criteria:

• Age 18 to 40 years
• Diagnosis of cancer between the ages of 15 and 40
• Female genitalia, regardless of gender
• Diagnosed with sexual dysfunction
• Complete Remission and at least two months from a major treatment
• Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial
• Ability to participate in study modules and to respond to surveys
• Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

• Patients receiving other investigational agents
• Patients expected to be neutropenic or have a significantly high infection risk that would exclude them from vaginal penetration
• Patients who are unable complete the study intervention or surveys